New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: A comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine
S. Krudsood, S. Looareesuwan, N. Tangpukdee, P. Wilairatana, W. Phumratanaprapin, W. Leowattana, K. Chalermrut, S. Ramanathan, V. Navaratnam, P. Olliaro, M. Vaillant, J. R. Kiechel, W. R.J. Taylor
Research output: Contribution to journal › Article › Research › peer-review
30Citations
(Scopus)
Fingerprint
Dive into the research topics of 'New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: A comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine'. Together they form a unique fingerprint.